Research
An open-source analysis framework developed by researchers at EMBL, HHU, and other institutions makes it easier to study how cells are organised within tumours, paving the way for new insights into cancer biology Summary How cancer develops and responds to treatment depends not only on the tumour cells themselves but also on the complex ecosystem […]
read more
EMBL spin-off Epitome Therapeutics launches to advance precision epigenome editing
The spin-off aims to develop a new generation of precision medicines using epigenome editing to precisely regulate gene expression without altering DNA A newly launched EMBL spin-off, Epitome Therapeutics, aims to translate pioneering research in epigenome editing into a new generation of precision medicines. Co-founded by EMBL Group Leader Jamie Hackett, the company builds on cutting-edge […]
read more
Complex Simulations: New Findings on Proton Transport in Water
International research team simulates motions of a hydrated proton in full quantum detail Complex simulations – the most intricate of their kind to date – reveal how water governs the way protons move through it. They were carried out by an international research team led by scientists of Heidelberg University’s Institute for Physical Chemistry. Using […]
read more
“Every Cell Tells Its Own Story” – Aviv Regev Awarded the 2026 Meyenburg Prize
The 2026 Meyenburg Prize goes to bioinformatician and systems biologist Aviv Regev, head of research at the biotech company Genentech in San Francisco, USA. The scientist is considered a pioneer of single-cell genomics, a method that allows for the high-resolution measurement and analysis of gene activity in individual cells—a field of research that has fundamentally […]
read more
Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD
At Heidelberg University Hospital (UKHD), there is a new treatment option for certain patients with severe cardiac arrhythmias: an implantable defibrillator in which the electrode—unlike in conventional defibrillators—is placed outside the heart and blood vessels. This protects the blood vessels. In addition, the system can correct some arrhythmias using mild electrical impulses before an electric […]
read more
The Individual Genetic Background Shapes the Evolution of Cancer
Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has now demonstrated in mice that an organism’s genetic makeup significantly influences the course of cancer development. The findings, now published in Nature, provide new insights into […]
read more
Cell Signaling Technology Announces ISO 13485 Certification
Certification enables increased support for partners and customers with industry-leading antibody reagents for commercial applications. Danvers, MA, USA, July 16, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced that its Beverly, MA, US and Leiden, NL facilities have achieved ISO 13485:2016 certification for […]
read more
NovoTags: AI-designed proteins help scientists see inside living cells
Researchers have designed synthetic and inducible proteins that bind to bright fluorescent dyes with high specificity and affinity, significantly expanding the toolkit for multicolour imaging of proteins inside cells Summary Cells are like metropolises, home to millions of molecular residents. If one were to stand atop a high-rise, trying to identify most of its inhabitants […]
read more
Breakthrough Prize for former MPI scientist
Physicist Ulrich Haeberlen contributed to the award-winning “Myon g-2” project through his research. July 16, 2026 An international research group has been awarded the “Breakthrough Prize for Fundamental Physics” for its decades of work on the “Myon g-2” particle physics experiment. Among the 387 laureates is a former researcher at the Max Planck Institute for […]
read more
